Celldex Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.71750
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

25.50 0.56 (2.25%)

45.74% Fall from 52W High

1.4M

XNAS Volume

XNAS 15 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.5 / 100

Technically Moderately Bullish

61.2 / 100

1Yr Price target upside is 129%

13 analysts

Celldex Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

45.74% Fall from 52W High

SWOT Analysis

Celldex Therapeutics Inc. Live Price Chart